Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PERSOWN is a private digital health, diagnostics, and health information technology company focused on affordable point-of-care testing, interoperable health records, and AI-enabled analytics for underserved populations. The company positions its business around three linked offerings: PERSOWN Diagnostics for rapid electrochemistry-based testing, PERSOWN Connect for smartphone-enabled care delivery and health access, and PERSOWN Analytics for continuous analytics built with SAS technologies. PERSOWN has publicly highlighted sepsis as a major initial use case, including development of rapid point-of-care sepsis diagnostics and the SMASH-H sepsis monitoring and alerting platform. Its broader strategy is to combine diagnostics, patient data capture, telehealth connectivity, and analytics to support clinicians, researchers, governments, and community health networks, especially in developing countries. The company appears to be commercialization-stage in health technology and diagnostics infrastructure rather than a traditional therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PERSOWN.